The pen needles market is anticipated to reach USD 3.08 Billion by 2030, increasing from USD 1.81 Billion in 2024 at a CAGR of 9.2% The elderly population, due to factors such as insulin resistance ...

Novo Nordisk and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa's Competition Commission said ...

LONDON, Nov 14 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ... needles. There is evidence people in LMICs want to use pens.

Among them, 5,000 are children. “Insulin pens, which are more accurate, user-friendly, and associated with less pain when used with short and fine needles, significantly enhance their quality of ...

A pen can be set with a dial to dispense a given amount of insulin, and its needle tip can be quickly jabbed into the skin. Insulin from a vial has to be drawn out into a syringe with the patient ...

“My lab has been working on needle-free insulin alternatives these past three years,” professor Shyh-Dar Li said, with UBC Pharmaceutical Sciences. “We tried nasal sprays before landing on ...

According to Market.us, it is anticipated that the Pen Needles Market Size will reach approximately USD 10 billion by the year 2033. This projection indicates significant growth compared to its value ...

During a transition period expected to last through mid-2025, Ypsomed will serve as a contract manufacturer to maintain the supply of insulin pen needles while its production equipment is ...